| 2201 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2202 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2203 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
81 |
| 2204 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
29 |
| 2205 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2206 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2207 |
Bone Marrow |
Allogeneic |
Sickle Cell Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2208 |
Bone Marrow |
Allogeneic |
T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2209 |
Bone Marrow |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2210 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2211 |
Bone Marrow |
Allogeneic |
Very Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2212 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2213 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2214 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
67 |
| 2215 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2216 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2217 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2218 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
58 |
| 2219 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2220 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2221 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2222 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2223 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
52 |
| 2224 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2225 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2226 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2227 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2228 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2229 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
40 |
| 2230 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2231 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
35 |
| 2232 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2233 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2234 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
39 |
| 2235 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2236 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2237 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2238 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
19 |
| 2239 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2240 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2241 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2242 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
48 |
| 2243 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
47 |
| 2244 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2245 |
Apheresis |
Autologous |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2246 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
20 |
| 2247 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2248 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2249 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2250 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
44 |
| 2251 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2252 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
31 |
| 2253 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
30 |
| 2254 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2255 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
72 |
| 2256 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
58 |
| 2257 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2258 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
32 |
| 2259 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2260 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2261 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2262 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2263 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2264 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2265 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2266 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2267 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2268 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2269 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2270 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2271 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2272 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
87 |
| 2273 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2274 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2275 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2276 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
46 |
| 2277 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2278 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
46 |
| 2279 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
33 |
| 2280 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2281 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2282 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
69 |
| 2283 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2284 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2285 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2286 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2287 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2288 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2289 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2290 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2291 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
31 |
| 2292 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2293 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
73 |
| 2294 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
82 |
| 2295 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
73 |
| 2296 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2297 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2298 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
72 |
| 2299 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2300 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |